Workflow
Robotics and AI in Laboratory Research
icon
Search documents
Ginkgo Bioworks Reports Fourth Quarter and Full Year 2025 Financial Results, Announces Focus on Autonomous Labs Offerings and Divestiture of its Non-Core Biosecurity Business
Prnewswire· 2026-02-26 21:26
assets—5,796121,404Deferred income tax benefit(1,364)(936)(801)Loss on disposal of equipment—844842Non-cash lease expense30,08228,09528,313Non-cash in-process research and development—19,7969,182Accretion of discount on marketable securities(3,390)——Other non-cash activity2,0641,2243,194Changes in operating assets and liabilities:Accounts receivable ($357, $156 and $816 from related parties)(1,473)(4,725)50,068Prepaid expenses and other current assets(5,247)10,08510,473Operating lease right-of-use assets3,8 ...